The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study
| Autor: | Alice Caldiroli, Enrico Capuzzi, Agnese Tringali, Ilaria Tagliabue, Marco Turco, Andrea Fortunato, Matteo Sibilla, Caterina Montana, Laura Maggioni, Cristian Pellicioli, Matteo Marcatili, Roberto Nava, Giovanna Crespi, Fabrizia Colmegna, Massimiliano Buoli, Massimo Clerici |
|---|---|
| Přispěvatelé: | Caldiroli, A, Capuzzi, E, Tringali, A, Tagliabue, I, Turco, M, Fortunato, A, Sibilla, M, Montana, C, Maggioni, L, Pellicioli, C, Marcatili, M, Nava, R, Crespi, G, Colmegna, F, Buoli, M, Clerici, M |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Pandemic
Personality disorder SARS-CoV-2 Mental Disorders Psychotic symptom COVID-19 Outpatient Psychotic symptoms Anxiety Article Obsessive-compulsive symptoms Psychiatry and Mental health Outpatients Communicable Disease Control Humans Obsessive-compulsive symptom Personality disorders Pandemics Biological Psychiatry Retrospective Studies |
| Zdroj: | Psychiatry Research |
| Popis: | SARS-CoV-2 infection causes a pulmonary disease (COVID-19) which spread worldwide generating fear, anxiety, depression in the general population as well as among subjects affected by mental disorders. Little is known about which different psychopathological changes the pandemic caused among individuals affected by different psychiatric disorders, which represents the aim of the present study. Specific psychometric scales were administered at three time points: T0 as outbreak of pandemic, T1 as lockdown period, T2 as reopening. Descriptive analyses and linear regression models were performed. A total of 166 outpatients were included. Overall, psychometric scores showed a significant worsening at T1 with a mild improvement at T2. Only psychopathology in schizophrenia (SKZ) patients and obsessive-compulsive (OC) symptoms did not significantly improve at T2. Subjects affected by personality disorders (PDs) resulted to be more compromised in terms of general psychopathology than depressed and anxiety/OC ones, and showed more severe anxiety symptoms than SKZ patients. In conclusion, subjects affected by PDs require specific clinical attention during COVID-19 pandemic. Moreover, the worsening of SKZ and OC symptoms should be strictly monitored by clinicians, as these aspects did not improve with the end of lockdown measures. Further studies on larger samples are needed to confirm our results. ClinicalTrials.gov Identifier: NCT04694482. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|